60 ° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug
WASHINGTON, Feb. 8, 2018 /PRNewswire/ -- 60 Degrees Pharmaceuticals (60P) received Priority Review Designation from the United States Food and Drug Administration (USFDA) for Tafenoquine (TQ) for prevention of malaria in adults.
The FDA...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Malaria | New Drug Applications | USA Health